Skip to main content
Podcasts

Efficacy, Costs of Fecal Microbiota Transplantation for Gastrointestinal Diseases

Maria Asimopoulos

 

Headshot of Gil Melmed, Cedars Sinai, on a blue background underneath the PopHealth Perspectives logo.Gil Melmed, MD, gastroenterologist, Cedars Sinai, Los Angeles, provides insight on fecal microbiota transplantation, including its cost-effectiveness, limitations, and use in treating gastrointestinal diseases such as Clostridioides difficile.